Hypercapnia in Hemodialysis (HD)

D. Tovbin
{"title":"Hypercapnia in Hemodialysis (HD)","authors":"D. Tovbin","doi":"10.33552/aun.2019.01.000508","DOIUrl":null,"url":null,"abstract":"Acute intra-dialytic exacerbation of hypercapnia in hemodialysis (HD) patient has been initially reported 18 years ago [1]. Subsequent similar case was reported few years later [2]. Common features of both patients were morbid obesity, a previously stable HD sessions and an acute respiratory infection at time of hypercapnia [1,2]. HD patients with decreased ventilation reserve, due to morbid obesity with or without obstructive sleep apnea (OSA) and/or obesity hypoventilation syndrome (OHS) as well as chronic obstructive pulmonary disease (COPD), are at increased risk. COPD is common among HD patients but frequently under-diagnosed [3]. Most COPD patients do well during HD with only mildmoderate pCO2 increases and slightly decreased pH as compared to non-COPD chronic HD patients [2,4]. However, acute pulmonary congestion or infection or gradual but significant deterioration in respiratory state, may induce hypercapnia with intradialytic exacerbation, hypercapnic encephalopathy and respiratory arrest [1,2,5]. A proposed mechanism is that tissue hypoxia due to hypoxemia and/ or low tissue perfusion as in sepsis and/or shock increase intradialytic acid generation, bicarbonate buffering and production of CO2, which cannot be exhaled at those states [1,2]. Some patients with severe COPD or OHS have baseline chronic severe hypercapnia and need the special measures which will be described below when starting hemodialysis. Symptoms of hypercapnic encephalopathy are correlated stronger with the changes in cerebrospinal pH induced by rapid diffusion of CO2, than with those of arterial pH and/or PCO2. Both hypoxemia and on the other hand uncontrolled oxygen therapy with high inspiratory oxygen fractions (FiO2), which further decrease respiratory drive, have deleterious effects [5]. Nowadays, morbid obesity and associated obstructive sleep apnea (OSA) and possibly obesity hypoventilation syndrome (OHS) are common in the general population and even more in the population at risk for reaching HD [6-8]. Non-invasive positive pressure ventilation (NIPPV) such as continuous positive airway pressure (CPAP) and bi-level positive airway pressure (BiPAP) are nowadays commonly used in hypercapnic patients [5,9,10]. In the 2 case reports and in our experience with similar patients, BiPAP prevented intra-dialytic exacerbation of hypercapnia and possibly respiratory arrest [1,2]. In recent years, new interest was raised to HD dialysate bicarbonate concentration. After standardizing to inflammation malnutrition complex and comorbidities midweek pre-dialysis serum bicarbonate level was recommended as >22 mEq/L [11]. As higher dialysate bicarbonate concentration became more prevalent, a large observation cohort study demonstrated that high dialysate bicarbonate concentration was associated with worse outcome especially in the more acidotic patients [12]. However, still not enough attention is paid to HD dialysate bicarbonate in the increasing number of patients with impaired ventilation, and to their risk of intra-dialytic exacerbation of hypercapnia, hypercapnic encephalopathy and respiratory arrest, especially during pulmonary infection and/or congestion. Thus, avoidance of complications while still correcting metabolic acidosis is a major challenge in these patients. In addition to NIPPV, the second preventive and therapeutic measures of this complication is to reduce dialysate bicarbonate concentration even more than the lower concentrations traditionally used of 33-34 mEq/L [1,2]. Thus, acidosis correction in these situations is dependent on intensive oral sodium bicarbonate between HD sessions [1], similarly to patients without ventilation impairment [13], but with higher doses. In summary, in the increasing number of HD patients with severe acute and/or chronic hypercapnia, lower dialysate bicarbonate concentration to decrease CO2 production, BiPAP during HD to increase CO2 removal, and high dose sodium bicarbonate administration between HD sessions, are probably required to modulate intradialytic exacerbation of hypercapnia as well as metabolic acidosis.","PeriodicalId":93263,"journal":{"name":"Annals of urology & nephrology","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of urology & nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33552/aun.2019.01.000508","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Acute intra-dialytic exacerbation of hypercapnia in hemodialysis (HD) patient has been initially reported 18 years ago [1]. Subsequent similar case was reported few years later [2]. Common features of both patients were morbid obesity, a previously stable HD sessions and an acute respiratory infection at time of hypercapnia [1,2]. HD patients with decreased ventilation reserve, due to morbid obesity with or without obstructive sleep apnea (OSA) and/or obesity hypoventilation syndrome (OHS) as well as chronic obstructive pulmonary disease (COPD), are at increased risk. COPD is common among HD patients but frequently under-diagnosed [3]. Most COPD patients do well during HD with only mildmoderate pCO2 increases and slightly decreased pH as compared to non-COPD chronic HD patients [2,4]. However, acute pulmonary congestion or infection or gradual but significant deterioration in respiratory state, may induce hypercapnia with intradialytic exacerbation, hypercapnic encephalopathy and respiratory arrest [1,2,5]. A proposed mechanism is that tissue hypoxia due to hypoxemia and/ or low tissue perfusion as in sepsis and/or shock increase intradialytic acid generation, bicarbonate buffering and production of CO2, which cannot be exhaled at those states [1,2]. Some patients with severe COPD or OHS have baseline chronic severe hypercapnia and need the special measures which will be described below when starting hemodialysis. Symptoms of hypercapnic encephalopathy are correlated stronger with the changes in cerebrospinal pH induced by rapid diffusion of CO2, than with those of arterial pH and/or PCO2. Both hypoxemia and on the other hand uncontrolled oxygen therapy with high inspiratory oxygen fractions (FiO2), which further decrease respiratory drive, have deleterious effects [5]. Nowadays, morbid obesity and associated obstructive sleep apnea (OSA) and possibly obesity hypoventilation syndrome (OHS) are common in the general population and even more in the population at risk for reaching HD [6-8]. Non-invasive positive pressure ventilation (NIPPV) such as continuous positive airway pressure (CPAP) and bi-level positive airway pressure (BiPAP) are nowadays commonly used in hypercapnic patients [5,9,10]. In the 2 case reports and in our experience with similar patients, BiPAP prevented intra-dialytic exacerbation of hypercapnia and possibly respiratory arrest [1,2]. In recent years, new interest was raised to HD dialysate bicarbonate concentration. After standardizing to inflammation malnutrition complex and comorbidities midweek pre-dialysis serum bicarbonate level was recommended as >22 mEq/L [11]. As higher dialysate bicarbonate concentration became more prevalent, a large observation cohort study demonstrated that high dialysate bicarbonate concentration was associated with worse outcome especially in the more acidotic patients [12]. However, still not enough attention is paid to HD dialysate bicarbonate in the increasing number of patients with impaired ventilation, and to their risk of intra-dialytic exacerbation of hypercapnia, hypercapnic encephalopathy and respiratory arrest, especially during pulmonary infection and/or congestion. Thus, avoidance of complications while still correcting metabolic acidosis is a major challenge in these patients. In addition to NIPPV, the second preventive and therapeutic measures of this complication is to reduce dialysate bicarbonate concentration even more than the lower concentrations traditionally used of 33-34 mEq/L [1,2]. Thus, acidosis correction in these situations is dependent on intensive oral sodium bicarbonate between HD sessions [1], similarly to patients without ventilation impairment [13], but with higher doses. In summary, in the increasing number of HD patients with severe acute and/or chronic hypercapnia, lower dialysate bicarbonate concentration to decrease CO2 production, BiPAP during HD to increase CO2 removal, and high dose sodium bicarbonate administration between HD sessions, are probably required to modulate intradialytic exacerbation of hypercapnia as well as metabolic acidosis.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血液透析中的高碳酸血症(HD)
18年前首次报道了血液透析(HD)患者高碳酸血症的急性透析内加重[10]。随后的类似案例在几年后的2010年被报道。这两例患者的共同特征是病态肥胖、先前稳定的HD病程和高碳酸血症时的急性呼吸道感染[1,2]。伴有或不伴有阻塞性睡眠呼吸暂停(OSA)和/或肥胖低通气综合征(OHS)以及慢性阻塞性肺疾病(COPD)的病态肥胖患者,其通气储备减少的风险增加。慢性阻塞性肺病在HD患者中很常见,但经常被误诊为[3]。与非COPD慢性HD患者相比,大多数COPD患者在HD期间表现良好,只有轻度中度pCO2升高和轻微的pH降低[2,4]。然而,急性肺充血或感染或逐渐但明显的呼吸状态恶化,可诱发高碳酸血症伴溶内加重、高碳酸血症性脑病和呼吸骤停[1,2,5]。一种被提出的机制是,脓毒症和/或休克中低氧血症和/或低组织灌注引起的组织缺氧增加了分析内酸的生成、碳酸氢盐缓冲和二氧化碳的产生,而在这些状态下二氧化碳无法呼出[1,2]。一些患有严重慢性阻塞性肺病或OHS的患者有基线慢性严重高碳酸血症,需要在开始血液透析时采取下文所述的特殊措施。高碳酸血症性脑病的症状与CO2快速扩散引起的脑脊液pH值变化的相关性强于与动脉pH值和/或PCO2的相关性。低氧血症和另一方面高吸气氧分数(FiO2)的无控制氧治疗,进一步降低呼吸驱动,都有有害的影响。如今,病态肥胖及其相关的阻塞性睡眠呼吸暂停(OSA)和可能的肥胖低通气综合征(OHS)在普通人群中很常见,在HD高危人群中更为常见[6-8]。无创正压通气(NIPPV)如持续气道正压通气(CPAP)和双水平气道正压通气(BiPAP)是目前高碳酸血症患者常用的通气方法[5,9,10]。在这2例病例报告和我们对类似患者的经验中,BiPAP可预防透析内高碳酸血症加重和可能的呼吸骤停[1,2]。近年来,HD透析液碳酸氢盐浓度的研究引起了人们新的关注。在对炎症、营养不良和合并症进行标准化后,周中透析前血清碳酸氢盐水平推荐为>22 mEq/L[11]。随着较高的碳酸氢钠透析液浓度变得越来越普遍,一项大型观察队列研究表明,较高的碳酸氢钠透析液浓度与较差的预后相关,尤其是在更多的酸中毒患者中。然而,在越来越多的通气功能受损患者中,HD透析碳酸氢盐仍然没有得到足够的重视,以及他们透析时高碳酸血症、高碳酸血症性脑病和呼吸骤停加剧的风险,特别是在肺部感染和/或充血期间。因此,在纠正代谢性酸中毒的同时避免并发症是这些患者的主要挑战。除NIPPV外,该并发症的第二个预防和治疗措施是降低透析液碳酸氢盐浓度,甚至超过传统使用的33-34 mEq/L的较低浓度[1,2]。因此,在这些情况下,酸中毒纠正依赖于在HD期间强化口服碳酸氢钠[1],类似于没有通气障碍的患者[13],但剂量更高。总之,在越来越多的伴有严重急性和/或慢性高碳酸血症的HD患者中,可能需要降低透析液的碳酸氢钠浓度来减少二氧化碳的产生,在HD期间使用BiPAP来增加二氧化碳的去除,以及在HD期间使用高剂量碳酸氢钠来调节高碳酸血症的分析内加重以及代谢性酸中毒。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Association Between Blood Flow Rate of Arteriovenous Access and Mortality in Prevalent Haemodialysis Patients: A Five-Year Prospective Study A Case of Severe Acute Hyperphosphatemia Secondary to Ingestion of Phosphoric Acid Solution Treated with Continuous Renal Replacement Therapy Considerations in the Management of Covid-19 in Patients with Chronic Kidney Disease NSAIDs, Dehydration and Acute Kidney Failure in the Young Adults: An Unrecognized Entity? Traumatic Urethrovaginal Fistula from Female Genital Mutilation Presenting as Bladder Outlet Obstruction: A Rare Case Report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1